Activity of serotonin (5-HT) receptor agonists, partial agonists and antagonists at cloned human 5-HT1A receptors that are negatively coupled to adenylate cyclase in permanently transfected HeLa cells.

[1]  J. Leysen,et al.  In vitro and in vivo receptor binding and effects on monoamine turnover in rat brain regions of the novel antipsychotics risperidone and ocaperidone. , 1992, Molecular pharmacology.

[2]  P. Albert,et al.  Cell-specific signaling of the 5-HT1A receptor. Modulation by protein kinases C and A. , 1991, Journal of Biological Chemistry.

[3]  R. Myers,et al.  Primary structure and functional expression of the 5HT3 receptor, a serotonin-gated ion channel. , 1991, Science.

[4]  D. Hoyer,et al.  Second Messengers in the Definition of 5-HT Receptors , 1991 .

[5]  M. Caron,et al.  Dual coupling of the cloned 5-HT1A receptor to both adenylyl cyclase and phospholipase C is mediated via the same Gi protein. , 1991, Cellular signalling.

[6]  R. Glennon,et al.  NAN-190: agonist and antagonist interactions with brain 5-HT1A receptors , 1990, Brain Research.

[7]  H. Kao,et al.  The molecular biology of serotonin receptors. An overview. , 1990, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.

[8]  H. V. Van Tol,et al.  Cloning, functional expression, and mRNA tissue distribution of the rat 5-hydroxytryptamine1A receptor gene. , 1990, The Journal of biological chemistry.

[9]  J. Bockaert,et al.  Pharmacological characterization of 5-hydroxytryptamine4(5-HT4) receptors positively coupled to adenylate cyclase in adult guinea pig hippocampal membranes: effect of substituted benzamide derivatives. , 1990, Molecular pharmacology.

[10]  D. Middlemiss,et al.  Characterization of MDL 73005EF as a 5‐HT1A selective ligand and its effects in animal models of anxiety: comparison with buspirone, 8‐OH‐DPAT and diazepam , 1990, British journal of pharmacology.

[11]  J. Leysen,et al.  Rapid desensitization and resensitization of 5-HT2 receptor mediated phosphatidyl inositol hydrolysis by serotonin agonists in quiescent calf aortic smooth muscle cells. , 1990, Life sciences.

[12]  A. Frazer,et al.  Subtypes of receptors for serotonin. , 1990, Annual review of pharmacology and toxicology.

[13]  J. Leysen,et al.  Beta-adrenoceptor-mediated cAMP accumulation in cardiac cells: effects of nebivolol. , 1989, European journal of pharmacology.

[14]  M. Caron,et al.  Effector coupling mechanisms of the cloned 5-HT1A receptor. , 1989, The Journal of biological chemistry.

[15]  R. North,et al.  5-HT3 receptors are membrane ion channels , 1989, Nature.

[16]  J. Leysen,et al.  The Receptor Binding Profile of the New Antihypertensive Agent Nebivolol and its Stereoisomers Compared with Various β-Adrenergic Blockers , 1988, Molecular pharmacology.

[17]  D. Hoyer,et al.  Centrally acting hypotensive agents with affinity for 5‐HT1A binding sites inhibit forskolin‐stimulated adenylate cyclase activity in calf hippocampus , 1988, British journal of pharmacology.

[18]  J. Bockaert,et al.  Pharmacology of 5-hydroxytryptamine-1A receptors which inhibit cAMP production in hippocampal and cortical neurons in primary culture. , 1988, Molecular pharmacology.

[19]  Nelson Dl,et al.  Use of forskolin stimulated adenylate cyclase in rat hippocampus as a screen for compounds that act through 5-HT1A receptors. , 1988 .

[20]  M. De Vivo,et al.  Characterization of the 5-hydroxytryptamine1a receptor-mediated inhibition of forskolin-stimulated adenylate cyclase activity in guinea pig and rat hippocampal membranes. , 1986, The Journal of pharmacology and experimental therapeutics.

[21]  J. Leysen,et al.  Evidence that phospholipid turnover is the signal transducing system coupled to serotonin-S2 receptor sites. , 1985, Journal of Biological Chemistry.

[22]  C. Londos,et al.  A highly sensitive adenylate cyclase assay. , 1974, Analytical biochemistry.